| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1,645,224 | +28,894 | +11% | $56.94 | 287,962 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1,581,160 | +36,207 | +13% | $43.67 | 324,169 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1,093,095 | +21,090 | +6.5% | $51.83 | 345,259 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1,032,366 | +21,998 | +6.4% | $46.93 | 367,257 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | $6,790,320 | -108,189 | -29% | $62.76 | 259,068 | 03 Jan 2022 | Direct | F1, F2, F3 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $2,265,037 | +52,480 | +20% | $43.16 | 311,548 | 04 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Options Exercise | $1,654,865 | +42,476 | +14% | $38.96 | 354,024 | 04 Jan 2022 | Direct | F1, F2 |
| transaction | ST | Ordinary Shares, par value EUR 0.01 per share | Sale | $6,172,140 | -94,956 | -27% | $65.00 | 259,068 | 04 Jan 2022 | Direct | F1, F2 |
| holding | ST | Ordinary Shares, par value EUR 0.01 per share | 89,766 | 03 Jan 2022 | By Irrevocable Family Trust | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -28,894 | -100% | $0.000000* | 0 | 03 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 28,894 | $56.94 | Direct | F1, F5 |
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -36,207 | -100% | $0.000000* | 0 | 03 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 36,207 | $43.67 | Direct | F1, F6 |
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -21,090 | -75% | $0.000000 | 7,030 | 03 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 21,090 | $51.83 | Direct | F1, F7 |
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -21,998 | -50% | $0.000000 | 22,000 | 03 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 21,998 | $46.93 | Direct | F1, F8 |
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -52,480 | -100% | $0.000000* | 0 | 04 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 52,480 | $43.16 | Direct | F1, F9 |
| transaction | ST | Stock options to Buy | Options Exercise | $0 | -42,476 | -100% | $0.000000* | 0 | 04 Jan 2022 | Ordinary Shares, par value EUR 0.01 per share | 42,476 | $38.96 | Direct | F1, F10 |
| Id | Content |
|---|---|
| F1 | The transactions being reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 30, 2021. |
| F2 | Includes 240,759 unvested restricted stock units, of which 152,381 are subject to performance conditions. |
| F3 | Reflects the sale of an aggregate of 108,189 shares of common stock on January 3, 2022, at the weighted average sales price of $62.7635. The prices for these sales range from $62.20 to $63.38. The filer undertakes to provide, upon request by the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F4 | Represents shares held by an irrevocable family trust having a disinterested trustee for the benefit of the reporting person's spouse and children (the "Cote Family 2020 Irrevocable Trust"). |
| F5 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2016. |
| F6 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2018. |
| F7 | The option is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2019. On the date of this transaction, 21,090 options were exercisable. |
| F8 | These options are exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2020. On the date of this transaction, 21,998 options were exercisable. |
| F9 | The option grant is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2015. |
| F10 | The option is exercisable over four years at 25% per year, beginning on the first anniversary date of April 1, 2017. |